These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32846205)

  • 1. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
    Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
    J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):112. PubMed ID: 34657615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT.
    Barkoudah E; Claggett BL; Lewis EF; O'Meara E; Clausell N; Diaz R; Fleg JL; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
    J Card Fail; 2022 Sep; 28(9):1390-1397. PubMed ID: 35636727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
    Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Ljung Faxén U; Fermer ML; Broberg MA; Gan LM; Lund LH
    Eur Heart J; 2018 Oct; 39(37):3439-3450. PubMed ID: 30165580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between coronary microvascular dysfunction, atrial fibrillation and heart failure with preserved ejection fraction.
    Ozcan C; Allan T; Besser SA; de la Pena A; Blair J
    Am J Cardiovasc Dis; 2021; 11(1):29-38. PubMed ID: 33815917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.
    Platz E; Jhund PS; Claggett BL; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; McMurray JJ
    Eur J Heart Fail; 2018 Feb; 20(2):295-303. PubMed ID: 28872259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
    Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
    J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term events following catheter-ablation for atrial fibrillation in heart failure with preserved ejection fraction.
    Ishiguchi H; Yoshiga Y; Shimizu A; Ueyama T; Fukuda M; Kato T; Fujii S; Hisaoka M; Uchida T; Omuro T; Okamura T; Kobayashi S; Yano M
    ESC Heart Fail; 2022 Oct; 9(5):3505-3518. PubMed ID: 35894764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Erhardsson M; Ljung Faxén U; Venkateshvaran A; Svedlund S; Saraste A; Lagerström Fermer M; Gan LM; Shah SJ; Tromp J; Sp Lam C; Lund LH; Hage C
    ESC Heart Fail; 2023 Dec; 10(6):3729-3734. PubMed ID: 37920127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.